| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2658 |
| Trial ID | NCT04844086 |
| Disease | Non-Hodgkin's Lymphoma | Primary Mediastinal B-Cell Lymphoma | B-Cell Acute Lymphoblastic Leukemia | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RPM CD19-mbIL15-CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Eden BioCell Ltd. |
| Other ID(s) | Eden 2020-01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||